Patent application number | Description | Published |
20100056597 | INDOLEDIONE DERIVATIVE - A compound represented by the general formula (I-a): | 03-04-2010 |
20110009622 | LONG-CHAIN FATTY ACYL ELONGASE INHIBITOR COMPRISING ARYLSULFONYL DERIVATIVE AS ACTIVE INGREDIENT - [Problem] To provide compounds useful as preventives or remedies for circular system disorders, nervous system disorders, metabolic disorders, reproduction system disorders, digestive system disorders, neoplasm, infectious diseases, etc., or as herbicides. | 01-13-2011 |
20110015181 | ALKYLAMINOPYRIDINE DERIVATIVE - The present invention relates to a compound that is useful for treatment of, for example, hypertension, arteriosclerosis, bulimia and obesity because of having an antagonistic action to a neuropeptide Y receptor and is represented by formula (I) | 01-20-2011 |
20110124674 | 5/5-OR 5/6-MEMBERED CONDENSED RING CYCLOALKYLAMINE DERIVATIVE - Disclosed are a compound of a formula (I) and its pharmaceutically-acceptable salt: | 05-26-2011 |
20120028970 | HETEROARYLTHIOMETHYL PYRIDINE DERIVATIVE - The present invention relates to a compound represented by a formula (I): wherein X is a group represented by or the like; Y is a group represented by or the like; and Ar | 02-02-2012 |
20120028990 | 3 ARYL OR HETEROARYL-SUBSTITUTED INDOLE DERIVATIVE - A 3-aryl or heteroaryl-substituted indole derivative which is effective as a preventive or remedy for various diseases is provided. [Means for Resolution] A compound represented by a formula (I) or a pharmaceutically acceptable salt thereof is provided. In the formula, R1 represents a hydrogen atom, C1-6 alkyl et al; R2 represents a hydrogen atom, C1-6 alkyl et al; Z represents aryl or heteroaryl (with the proviso that imidazolyl is excluded); and W represents a group represented by the formula (w-1) or (w-2). In the formula, R3 represents C1-6 alkyl et al; Yl and Y2 both represent a hydrogen atom or Y1 and Y2 together form —CH2-CH2-; Q represents CH or N; Ar represents phenyl, furyl et al; R4 and R5 each independently represent a hydrogen atom or C1-6 alkyl or R4 and R5 together with the nitrogen atom form pyrrolidine et al. | 02-02-2012 |
20120035155 | INDOLE-2-CARBOXAMIDE DEIVATIVE - To provide an indole compound having a human QRFP receptor antagonistic activity and useful as a preventive or a remedy for various disorders. A compound of a formula (I) or a pharmaceutically-acceptable salt thereof is provided: [wherein, R | 02-09-2012 |
Patent application number | Description | Published |
20080275069 | Quinazoline Derivative - This invention provides a compound or its pharmaceutically-acceptable salt of formula (I) | 11-06-2008 |
20090137576 | Novel Piperidine Derivative - Disclosed is a substance having an antagonistic effect on the binding of histamine to a histamine H3 receptor or an inhibitory effect on the activity which a histamine H3 receptor constantly exhibits. A compound represented by the formula (I) or a pharmaceutically acceptable salt thereof; (I) | 05-28-2009 |
20090258871 | Aza-Substituted Spiro Derivatives - A compound of the following formula (I) or its pharmaceutically-acceptable salt is provided: | 10-15-2009 |
20090306375 | Process for production of 4(3H)-quinazolinone derivative - The present invention provides a process for producing a 4(3H)-quinazolinone derivative, which is useful as a medicinal substance, with better efficiency in an industrial scale. The process comprises the steps of reacting 4-hydroxy-N-tert-butoxycarbonylpiperidine with 4-fluoro-1-nitrobenzene in the presence of sodium hydride, reacting the resulting product with cyclobutanone, reducing the resulting product to give 4-(1-cyclobutyl-4-piperidinyl)oxyaniline, and reacting this compound with 2-methyl-5-trifluoromethyl-4H-3,1-benzoxazin-4-one to give 3-{4-[(1-cyclobutyl-4-piperidinyl)oxy]phenyl}-2-methyl-5-trifluoromethyl-4(3H)-quinazolinone. | 12-10-2009 |
20100168156 | Novel Benzoxathiine Derivative - Disclosed is a compound represented by the formula (I) below and a pharmaceutically acceptable salt thereof. | 07-01-2010 |